Terms: = Sarcomas AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Prognosis
27 results:
1. Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR-TKIs.
Gu Z; Huang P; Zhao J; Luo C; Liao L; Liu A; Huang L
Int J Cancer; 2024 Jun; 154(11):1979-1986. PubMed ID: 38353428
[TBL] [Abstract] [Full Text] [Related]
2. Clinical characteristics, treatment options, and prognosis of myeloid sarcoma: analysis using the SEER database.
Liang J; Yang L; Yang B; Tian Y; Ren J; Yang L
Hematology; 2023 Dec; 28(1):2247898. PubMed ID: 37594298
[TBL] [Abstract] [Full Text] [Related]
3. The FBXO32/ATR/atm axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression.
Lu Y; Huang P; Li Y; Liu W; Li J; Zhao R; Feng H; Shi C; Cao G
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):842-852. PubMed ID: 37227155
[TBL] [Abstract] [Full Text] [Related]
4. Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1).
Roser E; Harter P; Zocholl D; Denschlag D; Chekerov R; Wimberger P; Kurzeder C; Hasenburg A; Muallem MZ; Mustea A; Emons G; Zeimet AG; Beck F; Arndt T; Brucker SY; Kommoss S; Heitz F; Welz J; Egger EK; Kalder M; Buderath P; Klar M; Marth C; Ulrich UA; Weigel M; Traub L; Anthuber C; Strauss H; Hanker L; Link T; Kubiak K; Melekian B; Hornung D; Pölcher M; Lampe B; Krauß T; Keilholz U; Flörcken A; Pietzner K; Sehouli J
Int J Gynecol Cancer; 2023 Feb; 33(2):223-230. PubMed ID: 36631151
[TBL] [Abstract] [Full Text] [Related]
5. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma.
Yang Q; Bariani MV; Falahati A; Khosh A; Lastra RR; Siblini H; Boyer TG; Al-Hendy A
Cells; 2022 Jul; 11(14):. PubMed ID: 35883603
[TBL] [Abstract] [Full Text] [Related]
6. Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis.
Melone V; Salvati A; Palumbo D; Giurato G; Nassa G; Rizzo F; Palo L; Giordano A; Incoronato M; Vitale M; Mian C; Di Biase I; Cristiano S; Narciso V; Cantile M; Di Mauro A; Tatangelo F; Tafuto S; Modica R; Pivonello C; Salvatore M; Colao A; Weisz A; Tarallo R
J Transl Med; 2022 Jul; 20(1):306. PubMed ID: 35794609
[TBL] [Abstract] [Full Text] [Related]
7. Advances in targeted therapy for anaplastic thyroid carcinoma.
Qian C; Jiang L; Xu S; Wang J; Tan Z; Xin Y; Ge M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 50(6):685-693. PubMed ID: 35347921
[TBL] [Abstract] [Full Text] [Related]
8. [Bioinformatics analysis of differently expressed genes in osteoblastic sarcoma and screening of key genes].
Shen RK; Huang Z; Zhu X; Lin JH
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):147-154. PubMed ID: 35184458
[No Abstract] [Full Text] [Related]
9. Primary leiomyosarcoma of the thyroid gland.
Kaur M; Chatterjee D; Aggarwal P; Saini V
Indian J Pathol Microbiol; 2022; 65(1):142-144. PubMed ID: 35074980
[TBL] [Abstract] [Full Text] [Related]
10. Methylation-mediated silencing of protein kinase C zeta induces apoptosis avoidance through atm/CHK2 inactivation in dedifferentiated chondrosarcoma.
Shimada E; Matsumoto Y; Nakagawa M; Susuki Y; Endo M; Setsu N; Fujiwara T; Iida K; Nabeshima A; Yahiro K; Kimura A; Hirose T; Kanahori M; Oyama R; Oda Y; Nakashima Y
Br J Cancer; 2022 May; 126(9):1289-1300. PubMed ID: 35017658
[TBL] [Abstract] [Full Text] [Related]
11. Primary intratesticular rhabdomyosarcoma in children: a case report and review of the literature.
Yahaya JJ; Mremi A
J Med Case Rep; 2021 Jan; 15(1):37. PubMed ID: 33516251
[TBL] [Abstract] [Full Text] [Related]
12. Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy.
Iñiguez-Ariza NM; Jasim S; Ryder MM; Chintakuntlawar AV; Morris JC; Hilger CR; Menefee ME; Smallridge RC; Karlin NJ; Alcaino C; Bible KC
J Clin Endocrinol Metab; 2020 Jul; 105(7):e2346-57. PubMed ID: 32421817
[TBL] [Abstract] [Full Text] [Related]
13. The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma.
Kowalik A; Jurkowska M; Mierzejewska E; Ługowska I; Gos A; Szumera-Ciećkiewicz A; Zięba S; Koseła-Paterczyk H; van der Oord J; Dębiec-Rychter M; Szamotulska K; Siedlecki J; Rutkowski P
Melanoma Res; 2020 Aug; 30(4):348-357. PubMed ID: 32073511
[TBL] [Abstract] [Full Text] [Related]
14. Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case.
Stenman A; Hellgren LS; Jatta K; Hysek M; Zemmler M; Altena R; Nilsson IL; Bränström R; Zedenius J; Juhlin CC
Endocr Pathol; 2020 Mar; 31(1):77-83. PubMed ID: 32016808
[TBL] [Abstract] [Full Text] [Related]
15. Factors affecting survival in patients with endobronchial malignant mass after flexible Bronchoscopic cryotherapy: a cohort study.
Chung FT; Chou CL; Lo YL; Kuo CH; Wang TY; Wang CH; Huang HY; Lin HC; Chang CH; Lee CS; Chen HC; Lin SM
BMC Pulm Med; 2019 May; 19(1):101. PubMed ID: 31126271
[TBL] [Abstract] [Full Text] [Related]
16. Nonsquamous cell laryngeal cancers: Incidence, demographics, care patterns, and effect of surgery.
Torabi SJ; Cheraghlou S; Kasle DA; Savoca EL; Judson BL
Laryngoscope; 2019 Nov; 129(11):2496-2505. PubMed ID: 30632157
[TBL] [Abstract] [Full Text] [Related]
17. Peroxiredoxin 1 (PRDX1) Suppresses Progressions and Metastasis of Osteosarcoma and Fibrosarcoma of Bone.
Wang Y; Liu M; Yang P; Peng H
Med Sci Monit; 2018 Jun; 24():4113-4120. PubMed ID: 29908016
[TBL] [Abstract] [Full Text] [Related]
18. High expression of TRIM29 (atdC) contributes to poor prognosis and tumor metastasis by inducing epithelial‑mesenchymal transition in osteosarcoma.
Zeng SX; Cai QC; Guo CH; Zhi LQ; Dai X; Zhang DF; Ma W
Oncol Rep; 2017 Sep; 38(3):1645-1654. PubMed ID: 28731167
[TBL] [Abstract] [Full Text] [Related]
19. The Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug Sensitivity.
Chen SM; Chou WC; Hu LY; Hsiung CN; Chu HW; Huang YL; Hsu HM; Yu JC; Shen CY
PLoS One; 2015; 10(6):e0128472. PubMed ID: 26115122
[TBL] [Abstract] [Full Text] [Related]
20. HSP90 inhibition as a means of radiosensitizing resistant, aggressive soft tissue sarcomas.
Ernst A; Anders H; Kapfhammer H; Orth M; Hennel R; Seidl K; Winssinger N; Belka C; Unkel S; Lauber K
Cancer Lett; 2015 Sep; 365(2):211-22. PubMed ID: 26044951
[TBL] [Abstract] [Full Text] [Related]
[Next]
